Mangoceuticals (NASDAQ:MGRX) Stock, Quote.Headers.trade-ideas

Mangoceuticals

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

xr:d:DAE9HpS4rJc:9180,j:2728248388,t:23041414

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

COTY

MGRX

XXII

Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter

Screenshot 2024-09-25 at 8.34.28 PM

Health Care

Interview

General

Men&#39;s Telehealth Company&#39;s Plans To Change Men&#39;s Wellness

Screenshot 2024-09-04 at 5.36.44 PM

Biotech

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

Mangoceuticals Inc

Investors dumped a popular long-dated Treasury ETF at a record pace in December, fleeing the bond market as surging yields and fiscal uncertainty cast a shadow ahead of President-elect Donald Trump's return <a href="https://www.benzinga.com/topic/donald-trump">to the White House.</a>
The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>), the largest Treasury-focused exchange-traded fund with $50 billion in assets under management, recorded $5.5 billion in outflows last month. 
This marks the fund's largest single-month outflows in its history, surpassing the $4 billion withdrawn during the pandemic-driven turmoil in March 2020.
On the performance front, the fund tumbled by 7.1% in December, recording the worst drop since September 2023. 
<h3 class="wp-block-heading">Chart: TLT ETF Witnessed Record Monthly Outflows In December</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="541" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02151804/image-8-1024x541.png" alt="" class="wp-image-715974" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02151804/image-8-1024x541.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02151804/image-8-300x159.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02151804/image-8-768x406.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02151804/image-8-1536x812.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02151804/image-8.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">Yields Soar As Trump Policies Ignite Inflation Risks</h3>
Yields on 30-year Treasury bonds climbed sharply, gaining more than 40 basis points in December to close the year at 4.80%. That's the highest level in over a year, driven by concerns about rising inflation and shifting monetary policy.
The Federal Reserve, which delivered a 25-basis-point interest rate cut in December, sounded hawkish in its accompanying guidance.
Officials signaled fewer rate cuts in 2025 than markets had expected and raised inflation forecasts to reflect upcoming administration policies.
&#8220;The&nbsp;Bond&nbsp;Vigilantes are sending a loud warning message,&#8221; said Ed Yardeni, president of Yardeni Research, in a recent note. 
&#8220;They aren&#8217;t convinced Donald Trump, the new sheriff coming to town, will maintain fiscal law and order any better than the old sheriff. They are also losing their confidence in Jerome Powell, the deputy in charge of monetary law and order,&#8221; he added.
In a recent report, Bravos Research highlighted that&nbsp;the 10-year&nbsp;Treasury&nbsp;yield&nbsp;rocketed from 3.6% in September to 4.6% in late December, implying a 25% increase in just 100 trading sessions.
&#8220;Moves like this are rare and have massive implications for the stock market,&#8221; the Bravos Research Team wrote. 
<h3 class="wp-block-heading">Trump's Policies Add To Market Jitters</h3>
Investor anxiety over Trump's incoming administration added another layer of complexity to the bond market.
Trump has floated the idea of scrapping the federal debt ceiling, a controversial move that could enable unchecked government borrowing and stoke inflationary pressures.
Such a policy would effectively remove a key restraint on federal deficits, raising alarm among bond investors already bracing for fiscal expansion.
"There's now more bad reasons for the rise in yields," Yardeni stated. 
As the expert highlighted, while stronger-than-expected economic data in the second half of 2024 initially pushed bond yields higher, the recent decline in the Citigroup Economic Surprise Index has shifted focus to structural concerns, such as persistent inflation risks and growing deficits.
Investors are also bracing for potential trade turbulence, as Trump has pledged to impose a universal 10% tariff and hike tariffs on Chinese imports to 60%. These measures, if enacted, could exacerbate inflationary pressures and add fuel to the bond market&#8217;s recent turmoil.
<h3 class="wp-block-heading">Treasury Department Breach Highlights New Risks</h3>
Compounding the challenges in December, the U.S. Treasury Department confirmed it was the target of a Chinese state-sponsored cyberattack. 
Hackers compromised a third-party vendor, BeyondTrust, and gained access to unclassified documents, according to a <a href="https://legacy.www.documentcloud.org/documents/25472740-letter-to-chairman-brown-and-ranking-member-scott/">letter</a> sent to lawmakers.
The major breach allowed hackers to override security protocols and access Treasury workstations via a stolen key. 
The Treasury Department said it became aware of the attack on Dec. 8 and is working with the FBI and the Cybersecurity and Infrastructure Security Agency (CISA) to assess the damage.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42768507/china-slaps-export-restrictions-on-dozens-of-us-companies-boeing-lockheed-martin-general-dynamics-raytheon-affected">China&#8217;s Export Crackdown Hits Boeing, Lockheed Martin And More</a></li>
</ul>
Photo: Shutterstock

Government

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

ETFs

iShares Trust Barclays 20+ Year Treasury Bond Fund

Investors Dump Long-Dated Treasury ETF At Record Pace Ahead Of Trump's White House Return

The company has rescheduled its conference call from the previously announced date of Thursday, January 9, 2025 in observance of the declared national day of mourning for former President Jimmy Carter.

Constellation Brands Reschedules Q3 Financial Results Release To January 10, 2025

Russian gas exports reportedly stopped running through Soviet-era Ukrainian pipelines on Wednesday after Ukraine refused to renew <a href="https://www.benzinga.com/news/econ-s/25/01/42769181/natural-gas-prices-surge-as-arctic-blast-freezes-us-3-stocks-on-the-move">a transit agreement.</a>
The Details: Russia's gas firm Gazprom said the gas stopped at 0500 GMT after Ukraine refused to renew the transit agreement in a widely anticipated move.  
Reuters reported that Ukrainian President Volodymyr Zelenskyy wrote on Telegram that the end of Russian natural gas flows through Ukraine was &#8220;one of Moscow&#8217;s biggest defeats.&#8221;&nbsp;
Zelenskyy also encouraged allies to supply more gas to Europe to fill the gap left by the end of the Russian supply.&nbsp;
&#8220;The more there is on the market from Europe&#8217;s real partners, the faster we will overcome the last negative consequences of European energy dependence on Russia,&#8221; he wrote.
Read Next: <a href="https://www.benzinga.com/news/global/24/12/42743937/natural-gas-prices-spike-as-bone-chilling-arctic-blast-approaches">Natural Gas Prices Spike As &#8216;Bone-Chilling&#8217; Arctic Blast Approaches</a>
Shares of U.S.-based liquified natural gas exporters, including Devon Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) and Cheniere Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>), are up Thursday as LNG exports to Europe are expected to rise in 2025. 
"Cheniere's LNG has been a vital part of the European response to Russia's war in Ukraine and has shown how security of supply, in the form of reliability of production and flexibility of delivery, are vastly important for this moment, and for the decades to come," Corey Grindal, COO of Cheniere Energy said in a 2023<a href="https://www.lng2023.org/news/cheniere-key-contributor-european-energy-security"> interview</a>.&nbsp;
"Cheniere produced about 11% of all LNG worldwide in 2022 and more than 70% of Cheniere's LNG was exported to Europe, by Cheniere or our customers," Grindal added.&nbsp;
The European Commission released a statement stating that the EU had anticipated and prepared for the stoppage of Russian gas flows.&nbsp;
‘&#8221;The European gas infrastructure is flexible enough to provide gas of non-Russian origin,&#8221; a spokesperson for the commission said. &#8220;It has been reinforced with significant new LNG (liquefied natural gas) import capacities since 2022.&#8221;
According to Reuters, Hungary will continue to receive Russian gas through the TurkStream pipeline and the last remaining European buyers of Russian gas, Slovakia and Austria, have arranged other supplies. &nbsp;
The Slovakian government said on Tuesday that there is no danger of a gas shortage and its state-owned gas firm SPP has gas supply contracts with large international suppliers including BP PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>), Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) and Shell PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>). 
Investors can monitor the broader energy sector through the SPDR Select Energy Sector Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) which tracks the S&amp;P Energy Select Sector Index, composed of 22 companies that primarily develop and produce crude oil and natural gas. 
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/42768507/china-slaps-export-restrictions-on-dozens-of-us-companies-boeing-lockheed-martin-general-dynamics-raytheon-affected">China&#8217;s Export Crackdown Hits Boeing, Lockheed Martin And More&nbsp;</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

Eurozone

Commodities

Global

Movers

SHEL

Russian Natural Gas Delivery To Europe Halted: US-Listed LNG Stocks Gain As Exports Set To Increase In 2025

Act III has agreed to a customary standstill, voting commitment, and related provisions in connection with the Cooperation Agreement.

BJRI

BJ's Restaurants Enters Cooperation Agreement With Act III Holdings, LLC And Various Affiliates Of Ronald M. Shaich

President-elect Donald Trump said the deadly New Orleans attack was a good reason to crack down on immigration even though the attacker, identified by authorities as Shamsud-Din Jabbar, was born and raised in the United States and <a href="https://www.benzinga.com/news/25/01/42772041/fbi-confirms-lone-suspect-in-new-orleans-attack-vegas-probe-ongoing">served in the U.S. Army</a>.
Building on an earlier <a href="https://truthsocial.com/@realDonaldTrump/posts/113757022203490348">Truth Social rant</a> shortly after the terrorist attack in which Trump called the U.S. a laughing stock and blamed the "open borders" of the Biden administration, he <a href="https://truthsocial.com/@realDonaldTrump/posts/113757022203490348">let loose again on Thursday</a>, referring to "the outside and inside violent SCUM that has infiltrated all aspects of our government, and our Nation itself."
Trump used the New Orleans attack that killed at least 14 people and injured dozens more to bash the FBI, the Department of Justice and other agencies. He called on the CIA to get involved even though the agency deals with foreign rather than domestic issues.
"The USA is breaking down &#8211; A violent erosion of Safety, National Security, and Democracy is taking place all across our Nation. Only strength and powerful leadership will stop it," Trump wrote.
President Joe Biden, who called the attack "despicable," expressed sympathy for the victims' families and the city of New Orleans.
"The situation is very fluid," said Biden, <a href="https://www.washingtonpost.com/nation/2025/01/01/new-orleans-vehicle-crowd-bourbon-street/">according</a> to the Washington Post. "The investigation is continuing to be active, and no one should jump to conclusions." Biden acknowledged that the perpetrator was an American citizen born in Texas who served in the U.S. Army and was likely influenced by the Islamic State.
"The FBI also reported to me that mere hours before the attack, he posted videos on social media indicating that [he] was inspired by ISIS," Biden said.
A top FBI official detailed the series of videos posted by the Bourbon Street attacker in which he claimed to have joined ISIS, <a href="https://www.nola.com/news/crime_police/bourbon-street-attack-isis/article_fd9d20e4-c927-11ef-8203-63f6eb3110b4.html">reported</a> nola.com.  
 &#8220;In the first video, Jabbar explains he originally planned to harm his family and friends, but was concerned the news headlines would not focus on the quote, &#8216;war between the believers and the disbelievers,&#8217; end quote,&#8221; Christopher Raia, deputy assistant director of the FBI&#8217;s Counterterrorism Division, reportedly said at a press conference.
Raia also <a href="https://www.nola.com/news/crime_police/bourbon-street-attack-isis/article_fd9d20e4-c927-11ef-8203-63f6eb3110b4.html">said</a> the FBI believes that Jabbar acted alone and that, at this point, no links have been uncovered between the New Orleans attack and the Tesla Cybertruck explosion in Las Vegas. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/sports/25/01/42771050/new-orleans-beefs-up-security-ahead-of-sugar-bowl-tickets-plummet-to-25-as-fans-leave-town">New Orleans Beefs Up Security Ahead Of Sugar Bowl, Tickets Plummet To $25 As Fans Leave Town</a></li>
</ul>
Photo via Shutterstock.

Politics

Media

Trump Calls FBI, DOJ 'Incompetent And Corrupt,' US A 'Laughing Stock' — Biden Calls NOLA Attack 'Despicable,' Expresses Sympathy For Victims' Families

Automatic Data Processing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) has outperformed the market over the past 15 years by 2.19% on an annualized basis producing an average annual return of 13.66%. Currently, Automatic Data Processing has a market capitalization of $118.02 billion. 
Buying $100 In ADP: If an investor had bought $100 of ADP stock 15 years ago, it would be worth $681.85 today based on a price of $289.65 for ADP at the time of writing.
<h3>Automatic Data Processing's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735853410_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Automatic Data Processing Stock In The Last 15 Years

That includes $2.23 billion domestically and $3.23 billion internationally. Disney is the first studio to surpass $5 billion worldwide since 2019 and has been No. 1 for 8 of the past 9 consecutive years globally.

Walt Disney Studios Says It Topped 2024 Global Box Office, Bringing In $5.46B Around The World

Guerisoli and Lamb are existing directors of the Company.

Management

PNTG

Pennant Group Appoints Brent Guerisoli As Chairman And Scott Lamb As Lead Independent Director, Each Effective January 1, 2025

This change follows the recent announcement of the stock market closure on the original scheduled date. The Company's quarterly earnings press release will cross the wire after market close on January 10, 2025.

Earnings

WDFC

WD-40  Reschedules Q1 FY25 Earnings Conference Call To January 10, 2025

Joe Fisher has been appointed to the role of Chief Investment Officer in addition to his roles as President and Chief Financial Officer.

UDR Promotes Mike Lacy To COO; Plans To Initiate An Executive Search Process To Recruit  New CFO

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) has outperformed the market over the past 10 years by 6.38% on an annualized basis producing an average annual return of 17.58%. Currently, UnitedHealth Group has a market capitalization of $464.29 billion. 
Buying $100 In UNH: If an investor had bought $100 of UNH stock 10 years ago, it would be worth $510.02 today based on a price of $504.51 for UNH at the time of writing.
<h3>UnitedHealth Group's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735852508_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning UnitedHealth Group Stock In The Last 10 Years

Lifecore Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFCR#NASDAQ">LFCR</a>) announced its Q2 earnings on Thursday, January 2, 2025 at 04:05 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Lifecore Biomedical beat estimated earnings by 19.0%, reporting an EPS of $-0.25 versus an estimate of $-0.31.
Revenue was up $2.41 million from the same period last year.
<h3>Overview of Past Earnings</h3>
The company missed on EPS by $0.07 in the last quarter, resulting in a 14.000000000000002% increase share price change the following day.

To track all earnings releases for Lifecore Biomedical <a href="https://www.benzinga.com/quote/LFCR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LFCR

Lifecore Biomedical Earnings Report: Q2 Overview

Resources Connection (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGP#NASDAQ">RGP</a>) reported its Q2 earnings results on Thursday, January 2, 2025 at 04:10 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Resources Connection beat estimated earnings by 0.18%, reporting an EPS of $0.18 versus an estimate of $0.0.
Revenue was down $17.51 million from the same period last year.
<h3>Previous Earnings Records</h3>
The company missed on EPS by $0.03 in the last quarter, resulting in a 12.0% drop share price change the following day.
Here's a look at Resources Connection's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.03</td>
<td>0.07</td>
<td>0.05</td>
<td>0.18</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0</td>
<td>0.28</td>
<td>0.17</td>
<td>0.28</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>137.92M</td>
<td>140.60M</td>
<td>152.77M</td>
<td>161.94M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>136.94M</td>
<td>148.20M</td>
<td>151.31M</td>
<td>163.13M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Resources Connection <a href="https://www.benzinga.com/quote/RGP/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Resources Connection Q2 Earnings

WIIM

CHEK

Check-Cap shares are trading higher after the company announced it was granted European Patent Number EP4087488 titled "RADIATION CAPSULE FOR BOWEL DISEASE IMAGING AND LOCALIZE DRUG DELIVERY".

Resources Connection (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGP#NASDAQ">RGP</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of undefined by Infinity percent. The company reported quarterly sales of $145.60 million which beat the analyst consensus estimate of $137.02 million by 6.26 percent. This is a 10.74 percent decrease over sales of $163.13 million the same period last year.

Earnings Beats

Resources Connection Q2 2025 Adj EPS $0.18 Beats $0 Estimate, Sales $145.60M Beat $137.02M Estimate

SPSC

Sps Commerce Announces It Has Reached An Agreement To Acquire CARBON6 Technologies, Inc; Terms Not Disclosed

Yum! Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>), the parent company of <a href="https://www.benzinga.com/general/restaurants">KFC, Pizza Hut and Taco Bell</a>, is nearing a potential <a href="https://www.benzinga.com/topic/golden-cross">Golden Cross</a>, a bullish technical indicator that could signal a turnaround for the stock.
While the stock is down 3.9% in the past month, recent upgrades and growth initiatives could bring renewed momentum to the stock.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010225&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="629" height="492" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02083745/Screenshot-2025-01-02-at-5.51.03-PM.png" alt="" class="wp-image-715166" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02083745/Screenshot-2025-01-02-at-5.51.03-PM.png 629w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02083745/Screenshot-2025-01-02-at-5.51.03-PM-300x235.png 300w" sizes="(max-width: 629px) 100vw, 629px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010225&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
<h2 class="wp-block-heading">YUM Stock Chart Has Mixed Signals, As Golden Cross Looms</h2>
At $134.16, YUM stock sits just below key moving averages, creating a mixed technical picture:
<ul>
<li>Eight-day SMA: A bullish signal at $133.81, indicating slight upward momentum.</li>
<li>20-day, 50-day and 200-day SMAs: All hovering above the current price, signaling bearish conditions.</li>
<li>MACD: At a negative 0.55, it reinforces a bearish sentiment.</li>
<li>RSI: A neutral 46.54 suggests neither overbought nor oversold conditions.</li>
</ul>
However, the eight-day SMA edging above the price hints at brewing buying pressure, while a looming Golden Cross—where the 50-day SMA crosses above the 200-day SMA—could ignite bullish enthusiasm.
Read Also: <a href="https://www.benzinga.com/24/12/42679687/mcdonalds-evangelion-collaboration-advert-catches-elon-musks-eye-heres-what-the-techno-king-shared">McDonald&#8217;s Evangelion Collaboration Advert Catches Elon Musk&#8217;s Eye. Here&#8217;s What The Techno King Shared</a>
<h2 class="wp-block-heading">YUM Stock Investors: What To Watch</h2>
For YUM stock investors, the potential Golden Cross could serve as a signal to ride Yum's recovery wave, particularly with Argus projecting long-term earnings growth of 10%. If momentum continues, YUM stock might finally break past its resistance levels and begin its climb toward the $155 target.
While bears remain skeptical, citing mixed short-term signals, Yum's blend of technical potential and fundamental optimism is worth watching. 
Will the Golden Cross be the catalyst Yum needs? Investors might not have to wait much longer to find out.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42702291/fast-food-robots-smaller-stores-wholesale-clubs-retail-trends-for-2025">Fast-Food Robots, Smaller Stores, Wholesale Clubs: 2025 Retail Trends To Watch</a></li>
</ul>
Photo: Shutterstock

Technicals

Restaurants

Signals

Yum! Brands Nears Golden Cross As Investors Look For Bullish Signs

Lifecore Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFCR#NASDAQ">LFCR</a>) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.29) by 13.79 percent. The company reported quarterly sales of $32.60 million which beat the analyst consensus estimate of $29.75 million by 9.59 percent. This is a 8.13 percent increase over sales of $30.15 million the same period last year.

Lifecore Biomedical Q2 2025 GAAP EPS $(0.25) Beats $(0.29) Estimate, Sales $32.60M Beat $29.75M Estimate

PINE

Alpine Income Property Trust Acquires Lowe's Home Improvement For $22.5M

<h3>Gainers</h3>
<ul>
<li>SRIVARU Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVMH#NASDAQ">SVMH</a>) stock increased by 23.5% to $0.05 during Thursday's pre-market session. The company's market cap stands at $28.5 million. </li>
<li>EZGO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZGO#NASDAQ">EZGO</a>) stock increased by 21.01% to $0.99. The company's market cap stands at $2.5 million. </li>
<li>Ambow Education Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMBO#AMEX">AMBO</a>) stock moved upwards by 18.09% to $2.48. The market value of their outstanding shares is at $7.0 million. The company's, Q2 earnings came out 3 days ago. </li>
<li>Faraday Future (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) shares increased by 15.63% to $2.81. The market value of their outstanding shares is at $127.3 million. </li>
<li>Pinstripes Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNST#NYSE">PNST</a>) stock increased by 13.87% to $0.45. The market value of their outstanding shares is at $18.0 million. </li>
<li>Phoenix Motor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEV#NASDAQ">PEV</a>) shares increased by 13.33% to $0.34. The market value of their outstanding shares is at $12.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Nxu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXU#NASDAQ">NXU</a>) stock decreased by 10.4% to $0.95 during Thursday's pre-market session. The market value of their outstanding shares is at $15.7 million. </li>
<li>Thunder Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIEV#NASDAQ">AIEV</a>) shares declined by 8.41% to $0.4. The market value of their outstanding shares is at $20.4 million. </li>
<li>JX Luxventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXG#NASDAQ">JXG</a>) stock fell 7.49% to $0.99. The market value of their outstanding shares is at $6.0 million. </li>
<li>ZSPACE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) shares decreased by 7.31% to $14.73. The market value of their outstanding shares is at $332.4 million. </li>
<li>Tokyo Lifestyle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKLF#NASDAQ">TKLF</a>) shares decreased by 6.35% to $3.1. The company's market cap stands at $130.8 million. </li>
<li>Twin Vee PowerCats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) shares fell 5.97% to $0.52. The company's market cap stands at $7.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIEV

AMBO

EZGO

FFIE

PNST

SVMH

TKLF

VEEE

ZSPC

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

Mangoceuticals files to sell 16.17M shares of common stock for holders

Mangoceuticals, Inc. (MGRX) has shared an announcement. On August 22, 2024, a company successfully completed a partial sale of its Series B Preferr...

Mangoceuticals Raises Capital and Boosts CEO Perks

Mangoceuticals announces 1-for-15 reverse stock split

"Mangoceuticals (MGRX) learned earlier this morning that Eli Lilly (LLY) has made certain public claims alleging, and has stated that it has filed ...

Mangoceuticals 'refutes' claims by Eli Lilly regarding sale of tirzepatide

The latest update is out from Mangoceuticals, Inc. ( ($MGRX) ). Mangoceuticals, Inc. (MangoRx), a company specializing in men's health products via...

Mangoceuticals Defends Against Eli Lilly Allegations

Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit

Mangoceuticals (MGRX) announced that the Company received a letter on October 30, 2024 from The Nasdaq Stock Market indicating that the Company has...

Mangoceuticals regains full compliance with Nasdaq min bid price requirement

Mangoceuticals, Inc. ( ($MGRX) ) has issued an announcement. Mangoceuticals, Inc. has signed a 12-month consulting agreement with their CFO, Eugene...

Mangoceuticals Signs Consulting Deal with CFO Johnston

Mangoceuticals (MGRX) has launched an investigation into potential stock manipulation related to and following its recent reverse stock split, whic...

Mangoceuticals initiates investigation into potential stock manipulation

Mangoceuticals, Inc. ( ($MGRX) ) has issued an announcement. Mangoceuticals, Inc. has acquired a patent for mushroom-derived nutraceutical composit...

Mangoceuticals Expands with Patent Acquisition in Nutraceuticals

Screenshot 2024-07-24 at 5.47.14 PM

Emerging Markets

This Men&#39;s Telehealth Company Has A Unique Take On Telehealth And Products

Screenshot 2024-07-17 at 5.41.58 PM

Say Goodbye To Inconvenient TRT: Meet The Game-Changing Oral Testosterone Treatment - PRIME By MangoRx

Screenshot 2024-07-09 at 1.59.17 PM

Erectile Function Vs Erectile Dysfunction: How MangoRx&#39;s (NASDAQ: MGRX) Product Sets Itself Apart And Caters To A Large Market (Pun Intended)

Men's Telehealth Company's Plans To Change Men's Wellness

Press Releases

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

Shares of Healthcare Company Rise Following Product Availability Announcement

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

MangoRx Announces Formation of Strategy and Alternatives Committee

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

UPXI

China Jo-Jo Drugstores, Inc. - Ordinary Shares

China Jo-Jo Drugstores

Guardian Pharmacy Services, Inc. Class A Common Stock

Guardian Pharmacy Service

Walgreens Boots Alliance, Inc. - Common Stock

Comments

Mangoceuticals

Mangoceuticals (MGRX) Forecast

Mangoceuticals (NASDAQ:MGRX) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga